Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats
Resistance to antibacterial therapy requires the discovery of new methods for the treatment of infectious diseases. Lactoferrin (LTF) is a well-known naïve first-line defense protein. In the present study, we suggested the use of an adenoviral vector (Ad5) carrying the human gene encoding LTF for di...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/58 |
id |
doaj-81337627ea054bc38211dfeef730e62c |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elima Agatieva Said Ksembaev Mikhail Sokolov Vage Markosyan Ilnaz Gazizov Dmitry Tsyplakov Maxim Shmarov Irina Tutykhina Boris Naroditsky Denis Logunov Oskar Pozdeev Lidiya Morozova Kamilya Yapparova Rustem Islamov |
spellingShingle |
Elima Agatieva Said Ksembaev Mikhail Sokolov Vage Markosyan Ilnaz Gazizov Dmitry Tsyplakov Maxim Shmarov Irina Tutykhina Boris Naroditsky Denis Logunov Oskar Pozdeev Lidiya Morozova Kamilya Yapparova Rustem Islamov Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats Pharmaceutics maxillofacial area phlegmon rat gene therapy adenoviral vector human umbilical cord blood mononuclear cell lactoferrin gene |
author_facet |
Elima Agatieva Said Ksembaev Mikhail Sokolov Vage Markosyan Ilnaz Gazizov Dmitry Tsyplakov Maxim Shmarov Irina Tutykhina Boris Naroditsky Denis Logunov Oskar Pozdeev Lidiya Morozova Kamilya Yapparova Rustem Islamov |
author_sort |
Elima Agatieva |
title |
Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats |
title_short |
Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats |
title_full |
Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats |
title_fullStr |
Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats |
title_full_unstemmed |
Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats |
title_sort |
evaluation of direct and cell-mediated lactoferrin gene therapy for the maxillofacial area abscesses in rats |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2021-01-01 |
description |
Resistance to antibacterial therapy requires the discovery of new methods for the treatment of infectious diseases. Lactoferrin (LTF) is a well-known naïve first-line defense protein. In the present study, we suggested the use of an adenoviral vector (Ad5) carrying the human gene encoding LTF for direct and cell-mediated gene therapy of maxillofacial area phlegmon in rats. Abscesses were developed by injection of the purulent peritoneal exudate in the molar region of the medial surface of the mandible. At 3–4 days after phlegmon maturation, all rats received ceftriaxone and afterward were subcutaneously injected around the phlegmon with: (1) Ad5 carrying reporter <i>gfp</i> gene encoding green fluorescent protein (Ad5-GFP control group), (2) Ad5 carrying <i>LTF</i> gene (Ad5-LTF group), (3) human umbilical cord blood mononuclear cells (UCBC) transduced with Ad5-GFP (UCBC + Ad5-GFP group), and (4) UCBC transduced with Ad5-LTF (UCBC + Ad5-LTF group). Control rats developed symptoms considered to be related to systemic inflammation and were euthanized at 4–5 days from the beginning of the treatment. Rats from therapeutic groups demonstrated wound healing and recovery from the fifth to seventh day based on the type of therapy. Histological investigation of cervical lymph nodes revealed purulent lymphadenitis in control rats and activated lymphatic tissue in rats from the UCBC + Ad5-LTF group. Our results propose that both approaches of <i>LTF</i> gene delivery are efficient for maxillofacial area phlegmon recovery in rats. However, earlier wound healing and better outcomes in cervical lymph node remodeling in the UCBC + Ad5-LTF group, as well as the lack of direct exposure of the viral vector to the organism, which may cause toxic and immunogenic effects, suggest the benefit of cell-mediated gene therapy. |
topic |
maxillofacial area phlegmon rat gene therapy adenoviral vector human umbilical cord blood mononuclear cell lactoferrin gene |
url |
https://www.mdpi.com/1999-4923/13/1/58 |
work_keys_str_mv |
AT elimaagatieva evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT saidksembaev evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT mikhailsokolov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT vagemarkosyan evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT ilnazgazizov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT dmitrytsyplakov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT maximshmarov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT irinatutykhina evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT borisnaroditsky evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT denislogunov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT oskarpozdeev evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT lidiyamorozova evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT kamilyayapparova evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats AT rustemislamov evaluationofdirectandcellmediatedlactoferringenetherapyforthemaxillofacialareaabscessesinrats |
_version_ |
1724348774342459392 |
spelling |
doaj-81337627ea054bc38211dfeef730e62c2021-01-05T00:03:18ZengMDPI AGPharmaceutics1999-49232021-01-0113585810.3390/pharmaceutics13010058Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in RatsElima Agatieva0Said Ksembaev1Mikhail Sokolov2Vage Markosyan3Ilnaz Gazizov4Dmitry Tsyplakov5Maxim Shmarov6Irina Tutykhina7Boris Naroditsky8Denis Logunov9Oskar Pozdeev10Lidiya Morozova11Kamilya Yapparova12Rustem Islamov13Department of Maxillofacial Surgery and Surgical Dentistry, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Maxillofacial Surgery and Surgical Dentistry, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Operative Surgery and Topographic Anatomy, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Operative Surgery and Topographic Anatomy, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Operative Surgery and Topographic Anatomy, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Pathology, Kazan State Medical University, 420012 Kazan, RussiaThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, RussiaThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, RussiaThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, RussiaThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, RussiaDepartment of Microbiology, Kazan State Medical Academy, 420012 Kazan, RussiaDepartment of Microbiology, Kazan State Medical Academy, 420012 Kazan, RussiaDepartment of Medical Biology and Genetics, Kazan State Medical University, 420012 Kazan, RussiaDepartment of Medical Biology and Genetics, Kazan State Medical University, 420012 Kazan, RussiaResistance to antibacterial therapy requires the discovery of new methods for the treatment of infectious diseases. Lactoferrin (LTF) is a well-known naïve first-line defense protein. In the present study, we suggested the use of an adenoviral vector (Ad5) carrying the human gene encoding LTF for direct and cell-mediated gene therapy of maxillofacial area phlegmon in rats. Abscesses were developed by injection of the purulent peritoneal exudate in the molar region of the medial surface of the mandible. At 3–4 days after phlegmon maturation, all rats received ceftriaxone and afterward were subcutaneously injected around the phlegmon with: (1) Ad5 carrying reporter <i>gfp</i> gene encoding green fluorescent protein (Ad5-GFP control group), (2) Ad5 carrying <i>LTF</i> gene (Ad5-LTF group), (3) human umbilical cord blood mononuclear cells (UCBC) transduced with Ad5-GFP (UCBC + Ad5-GFP group), and (4) UCBC transduced with Ad5-LTF (UCBC + Ad5-LTF group). Control rats developed symptoms considered to be related to systemic inflammation and were euthanized at 4–5 days from the beginning of the treatment. Rats from therapeutic groups demonstrated wound healing and recovery from the fifth to seventh day based on the type of therapy. Histological investigation of cervical lymph nodes revealed purulent lymphadenitis in control rats and activated lymphatic tissue in rats from the UCBC + Ad5-LTF group. Our results propose that both approaches of <i>LTF</i> gene delivery are efficient for maxillofacial area phlegmon recovery in rats. However, earlier wound healing and better outcomes in cervical lymph node remodeling in the UCBC + Ad5-LTF group, as well as the lack of direct exposure of the viral vector to the organism, which may cause toxic and immunogenic effects, suggest the benefit of cell-mediated gene therapy.https://www.mdpi.com/1999-4923/13/1/58maxillofacial area phlegmonratgene therapyadenoviral vectorhuman umbilical cord blood mononuclear celllactoferrin gene |